Immunosuppressive After Lung Transplantation Clinical Trial
Official title:
Generic Immunosuppressive Drugs After Lung Transplantation - a Crosssectional Observational Study by Patient Questionnaire
Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation
Solid organ transplant recipients are treated with immunosuppressive drugs to prevent
rejection of their grafts. The most frequently important maintenance immunosuppressive drugs
in Europe are calcineurin inhibitors.
For a number of these compounds drug patents have expired in recent years and generic
formulations have entered the market. There is considerable debate regarding the efficacy
and safety of generic drug substitution in solid organ recipients.
;
Observational Model: Cohort, Time Perspective: Retrospective